Record NNP B-NP O
date NN I-NP O
: : O O
2080-12-18 CD O B-DATE
RENAL NNP B-NP O
TRANSPLANT NNP I-NP O
ADMIT NNP I-NP O
NOTE NNP I-NP O
12/18/8 CD I-NP I-DATE
0 CD O I-DATE
Cause VB B-NP O
of IN B-PP O
ESRD NNP B-NP O
: : O O
DM2 NNP B-NP O
, , O O
HTN . O O
Date NNP B-NP O
of IN B-PP O
this DT B-NP O
kidney NN I-NP O
transplant NN I-NP O
: : O O
11.08.80 CD B-NP B-DATE
; : O O
LURT NNP B-NP O
from IN B-PP O
step-son NN B-NP O
; : O O
share NN B-NP O
HLA-B NNP I-NP O
and CC O O
HLA-DR NNP B-NP O
; : O O
simulect JJ B-NP O
induction NN I-NP O
CC NNP B-NP O
: : O O
elevated JJ B-NP O
creatinine NN I-NP O
HPI NNP B-NP O
: : O O
Mr. NNP B-NP O
Sparks NNP I-NP B-PATIENT
is VBZ B-VP O
a DT B-NP O
76 CD I-NP B-AGE
y/o NN I-NP O
M NNP I-NP O
h/o VBD B-VP O
ESRD NNP B-NP O
2/2 CD I-NP O
DM NNP I-NP O
s/p NN I-NP O
LURTx NNP I-NP O
11/08/8 CD I-NP I-DATE
0 CD I-NP I-DATE
c/b NN I-NP O
delayed VBD B-VP O
graft JJ B-NP O
function NN I-NP O
. . O O
Pt NNP O O
. . O O
had VBD B-VP O
a DT B-NP O
renal JJ I-NP O
bx NN I-NP O
on IN B-PP O
11/23/8 CD B-NP I-DATE
0 CD I-NP I-DATE
c/w JJ I-NP O
ATN NNP I-NP O
, , O O
no DT B-NP O
acute JJ I-NP O
rejection NN I-NP O
. . O O
However RB B-ADVP O
, , O O
creatinine NN B-NP O
has VBZ B-VP O
failed VBN I-VP O
to TO I-VP O
fall VB I-VP O
below IN B-PP O
2 CD B-NP O
's POS B-VP O
despite IN B-PP O
treatment NN B-NP O
for IN B-PP O
UTI NNP B-NP O
and CC I-NP O
hydration NN I-NP O
. . O O
There EX B-NP O
has VBZ B-VP O
been VBN I-VP O
some DT B-NP O
question NN I-NP O
of IN B-PP O
medication NN B-NP O
compliance NN I-NP O
previously RB B-ADVP O
, , O O
as IN B-SBAR O
he PRP B-NP O
frequently RB B-ADVP O
confuses VBZ B-VP O
his PRP$ B-NP O
meds NNS I-NP O
. . B-PP O
His PRP$ B-NP O
FK NNP I-NP O
level NN I-NP O
has VBZ B-VP O
been VBN I-VP O
lowered VBN I-VP O
as IN B-PP O
a DT B-NP O
possible JJ I-NP O
source NN I-NP O
for IN B-PP O
his PRP$ B-NP O
allograft NN I-NP O
dysfunction NN I-NP O
. . O O
Mr. NNP B-NP O
Sparks NNP I-NP B-PATIENT
is VBZ B-VP O
being VBG I-VP O
admitted VBN I-VP O
for IN B-PP O
renal JJ B-NP O
transplant NN I-NP O
biopsy NN I-NP O
to TO B-VP O
r/o VB I-VP O
acute JJ B-NP O
rejection NN I-NP O
. . O O
Current JJ B-NP O
immunosuppression NN I-NP O
: : O O
tacrolimus JJ B-NP O
6mg JJ I-NP O
bid NN I-NP O
, , O O
MMF NNP B-NP O
750 CD I-NP O
mg NN I-NP O
tid NN I-NP O
Other JJ B-NP O
meds NNS I-NP O
: : O O
Valcyte NNP B-NP O
450mg CD I-NP O
qod NN I-NP O
, , O O
Bactrim NNP B-NP O
SS NNP I-NP O
1 CD I-NP O
qod NN I-NP O
, , O O
Diltiazem NNP B-NP O
ER NNP I-NP O
120mg CD I-NP O
qd NN I-NP O
, , O O
Hydralazine NNP B-NP O
25mg CD I-NP O
tid JJ I-NP O
, , I-NP O
CaCO3 JJ I-NP O
500mg JJ I-NP O
bid NN I-NP O
, , O O
Calcitriol NNP B-NP O
0.25mcg CD I-NP O
qd NN I-NP O
, , O O
Nexium NNP B-NP O
40mg CD I-NP O
qd NN I-NP O
, , O O
Flomax NNP B-NP O
0.8mg CD I-NP O
qd NN I-NP O
, , O O
insulin NN B-NP O
NPH NNP I-NP O
6U CD I-NP O
bid NN I-NP O
and CC O O
Novolog NNP B-NP O
5U JJ I-NP O
pre JJ I-NP O
meals NNS I-NP O
, , O O
Colace NNP B-NP O
qd NNP I-NP O
. . O O
PMHx NNP B-NP O
: : O O
ESRD NNP B-NP O
2/2 CD I-NP O
DM NNP I-NP O
and CC I-NP O
HTN NNP I-NP O
x NN I-NP O
10years VBZ B-VP O
- : O O
good JJ B-NP O
urine NN I-NP O
output NN I-NP O
prior RB B-ADVP O
to TO B-PP O
transplant NN B-NP O
. . O O
No DT B-NP O
retinopathy NN I-NP O
, , O O
CAD NNP B-NP O
, , O O
peripheral JJ B-NP O
neuropathy NN I-NP O
. . O O
-Adenomatous JJ B-NP O
polyp NN I-NP O
: : O O
May NNP B-NP B-DATE
2078 CD I-NP I-DATE
-Gastritis NN B-NP O
: : O O
H. NNP B-NP O
pylori FW I-NP O
positive JJ I-NP O
-Diastolic JJ B-NP O
dysfunction NN I-NP O
-Hyperlipidemia NN B-NP O
-Hyerparathyroidism NN B-NP O
- : O O
PTH DT B-NP O
367 CD B-NP O
in IN B-PP O
Nov NNP B-NP I-DATE
, , O I-DATE
2080 CD O I-DATE
-H/o JJ B-NP O
Transient NNP I-NP O
ischemic IN B-PP O
attack NN B-NP O
2073 CD I-NP B-DATE
-S/p JJ B-NP O
R NN I-NP O
Inguinal NNP I-NP O
Hernia NNP I-NP O
repair NN I-NP O
, , O O
2078 CD O B-DATE
-S/p JJ B-NP O
Umbilical JJ I-NP O
Hernia NNP I-NP O
repair NN I-NP O
, , O O
2079 CD O B-DATE
BKVL NNP B-NP O
Neg NNP I-NP O
11/8 CD I-NP I-DATE
0 CD O I-DATE
Exam NNP B-NP O
: : O O
Gen- NNP B-NP O
WD NNP I-NP O
, , O O
WN NNP B-NP O
, , O O
M NNP B-NP O
, , O O
NAD NNP B-NP O
Heent- NNP B-NP O
NC NNP I-NP O
, , O O
EOMI NNP B-NP O
, , O O
PERLA NNP B-NP O
, , O O
no DT B-NP O
LAD NN I-NP O
, , O O
OPC NNP B-NP O
Cor- NNP B-NP O
RRR NNP I-NP O
, , O O
nml NN B-NP O
S1S2 . O O
Lungs-CTA NNP B-NP O
b/l NN I-NP O
, , O O
no DT B-NP O
wheezing NN I-NP O
, , O O
no DT B-NP O
rhonchi NN I-NP O
Abd- NNP B-NP O
s/nt/nd NN I-NP O
, , O O
NABS NNP B-NP O
Ext- NNP B-NP O
No DT B-NP O
leg NN I-NP O
edema NN I-NP O
Neuro- NNP B-NP O
A&O NNP I-NP O
x NN I-NP O
3 CD O O
Today NN B-NP O
's POS B-NP O
Labs NNS I-NP O
: : O O
Date/Time NNP B-NP O
NA NNP I-NP O
K NNP I-NP O
CL NN I-NP O
CO2 . O O
12/18/2080 CD B-NP B-DATE
131 CD I-NP O
( -LRB- I-NP O
* NN I-NP O
) -RRB- I-NP O
5.2 CD I-NP O
( -LRB- I-NP O
* NN I-NP O
) -RRB- I-NP O
99 CD I-NP O
28 CD O O
12/17/2080 CD B-NP B-DATE
130 CD I-NP O
( -LRB- I-NP O
* NN I-NP O
) -RRB- I-NP O
4.9 CD I-NP O
98 CD I-NP O
26 CD O O
Date/Time NNP B-NP O
BUN NNP I-NP O
CRE NNP I-NP O
EGFR NNP I-NP O
GLU . O O
12/18/2080 CD B-NP B-DATE
46 CD I-NP O
( -LRB- I-NP O
* NN I-NP O
) -RRB- I-NP O
2.2 CD I-NP O
( -LRB- I-NP O
* NN I-NP O
) -RRB- I-NP O
31 CD I-NP O
[1 CD I-NP O
] NN I-NP O
132 CD B-NP O
( -LRB- I-NP O
*# NN I-NP O
) -RRB- O O
12/17/2080 CD B-NP B-DATE
41 CD I-NP O
( -LRB- I-NP O
* NN B-VP O
) -RRB- B-NP O
2.4 CD I-NP O
( -LRB- I-NP O
* NN I-NP O
) -RRB- B-PP O
28 CD B-NP O
[2 CD I-NP O
] NN I-NP O
298 CD B-NP O
( -LRB- I-NP O
* NN I-NP O
) -RRB- O O
Date/Time NNP B-NP O
ANION NN I-NP O
12/18/2080 CD B-NP B-DATE
4 CD I-NP O
12/17/2080 CD B-NP B-DATE
6 CD I-NP O
Date/Time NNP B-NP O
CA NNP I-NP O
PHOS NNP I-NP O
TBILI NNP I-NP O
TP NNP I-NP O
12/18/2080 CD B-NP B-DATE
9.9 CD I-NP O
12/17/2080 CD B-NP B-DATE
9.4 CD I-NP O
2.4 CD I-NP O
0.8 CD I-NP O
7.1 CD O O
Date/Time NNP B-NP O
ALB NNP I-NP O
GLOB NNP I-NP O
LDH NNP I-NP O
12/17/2080 IN B-PP B-DATE
3.9 CD B-NP O
3.2 CD I-NP O
156 CD O O
Date/Time NNP B-NP O
ALT/SGPT NNP I-NP O
AST/SGOT NNP I-NP O
ALKP NNP I-NP O
TBILI . O O
12/17/2080 CD B-NP B-DATE
12 CD I-NP O
24 CD I-NP O
162 CD I-NP O
( -LRB- I-NP O
* NN I-NP O
) -RRB- I-NP O
0.8 CD O O
Date/Time NNP B-NP O
LDH NNP I-NP O
12/17/2080 CD B-NP B-DATE
156 CD I-NP O
Date/Time NNP B-NP O
WBC NNP I-NP O
RBC NNP I-NP O
HGB NNP I-NP O
HCT . O O
12/18/2080 CD B-NP B-DATE
4.58 CD I-NP O
4.02 CD I-NP O
( -LRB- I-NP O
* NN I-NP O
) -RRB- I-NP O
11.3 CD I-NP O
( -LRB- I-NP O
* NN I-NP O
) -RRB- I-NP O
34.5 CD I-NP O
( -LRB- I-NP O
* NN I-NP O
) -RRB- O O
12/17/2080 CD B-NP B-DATE
5.36 CD I-NP O
4.07 CD I-NP O
( -LRB- I-NP O
* NN I-NP O
) -RRB- I-NP O
11.0 CD I-NP O
( -LRB- I-NP O
* NN I-NP O
) -RRB- I-NP O
35.3 CD I-NP O
( -LRB- I-NP O
* NN I-NP O
) -RRB- O O
Date/Time NNP B-NP O
MCV NNP I-NP O
MCH NNP I-NP O
MCHC NNP I-NP O
PLT . O O
12/18/2080 CD B-NP B-DATE
85.7 CD I-NP O
28.2 CD I-NP O
32.9 CD I-NP O
332 CD O O
12/17/2080 CD B-NP B-DATE
86.8 CD I-NP O
27.0 CD I-NP O
31.1 CD I-NP O
( -LRB- I-NP O
* NN I-NP O
) -RRB- I-NP O
314 CD O O
Date/Time NNP B-NP O
RDW NNP I-NP O
12/18/2080 CD B-NP B-DATE
13.4 CD I-NP O
12/17/2080 CD B-NP B-DATE
13.5 CD I-NP O
Date/Time NNP B-NP O
%POLY-A NNP I-NP O
%LYMPH-A NNP I-NP O
%MONO-A NNP I-NP O
%EOS-A . O O
12/17/2080 CD B-NP B-DATE
72.8 CD I-NP O
17.9 CD I-NP O
( -LRB- I-NP O
* NN I-NP O
) -RRB- I-NP O
7.0 CD I-NP O
1.9 CD O O
Date/Time NNP B-NP O
%BASO-A NNP I-NP O
12/17/2080 CD B-NP B-DATE
0.5 CD I-NP O
Date/Time NNP B-NP O
ANEUT-A NNP I-NP O
ALYMP-A NNP I-NP O
AMONO-A NNP I-NP O
AEOS-A NNP I-NP O
12/17/2080 CD B-NP B-DATE
3.91 CD I-NP O
.96 CD I-NP O
0.38 CD I-NP O
0.10 CD O O
Date/Time NNP B-NP O
ABASO-A NNP I-NP O
12/17/2080 CD B-NP B-DATE
0.02 CD I-NP O
Date/Time NNP B-NP O
PT NNP I-NP O
PT-INR NNP I-NP O
PTT NNP I-NP O
12/18/2080 CD B-NP B-DATE
13.9 CD I-NP O
1.1 CD I-NP O
31.4 CD O O
Date/Time NNP B-NP O
UA-COLOR NNP I-NP O
UA-GLUC NNP I-NP O
UA-BIL NNP I-NP O
I PRP B-NP O
UA-KET . O O
12/17/2080 CD B-NP B-DATE
YELLOW NNP I-NP O
[3 CD I-NP O
] , O O
NEG NNP B-NP O
NEG NNP I-NP O
NEG NNP I-NP O
Date/Time NNP B-NP O
UA-SPGR NNP I-NP O
UA-BLD NNP I-NP O
UA-PH NNP I-NP O
UA-PROT NNP I-NP O
12/17/2080 CD B-NP B-DATE
1.015 CD I-NP O
NEG NNP B-NP O
5.0 CD I-NP O
NEG . O O
Date/Time NNP B-NP O
UA-UROBI NNP I-NP O
UA-NIT NNP I-NP O
UA-WBC NNP I-NP O
MIC-SED . O O
12/17/2080 CD B-NP B-DATE
NEG NNP I-NP O
NEG NNP I-NP O
TR NNP I-NP O
( -LRB- I-NP O
* NN I-NP O
) -RRB- I-NP O
NEG . O O
Date/Time NNP B-NP O
OCAST NNP I-NP O
HCAST NNP I-NP O
UAS-RBC NNP I-NP O
UAS-WBC . O O
12/17/2080 CD B-NP B-DATE
NEG NNP I-NP O
0 CD I-NP O
1 CD I-NP O
5 CD I-NP O
( -LRB- I-NP O
* NN I-NP O
) -RRB- O O
Date/Time NNP B-NP O
UAS-BACT NNP I-NP O
UAS-SQHI NNP I-NP O
UAS-CRYS . O O
12/17/2080 CD B-NP B-DATE
NEG NNP I-NP O
TR NNP I-NP O
NEG NNP I-NP O
Date/Time NNP B-NP O
UA-EPIS CC O O
12/17/2080 CD B-NP B-DATE
NEG NN I-NP O
Date/Time NNP B-NP O
TACRO NNP I-NP O
12/17/2080 CD B-NP B-DATE
7.3 CD I-NP O
( -LRB- O O
C)[ NNP B-NP O
4 CD I-NP O
] . O O
A/P:Mr. NNP B-NP O
Sparks NNP I-NP B-PATIENT
is VBZ B-VP O
a DT B-NP O
76 CD I-NP B-AGE
y/o NN I-NP O
M NNP I-NP O
h/o VBD B-VP O
ESRD NNP B-NP O
2/2 CD I-NP O
DM NNP I-NP O
s/p NN I-NP O
LURTx NNP I-NP O
11/08/8 CD I-NP I-DATE
0 CD I-NP I-DATE
c/b NN I-NP O
delayed VBD B-VP O
graft JJ B-NP O
function NN I-NP O
. . O O
He PRP B-NP O
will MD B-VP O
be VB I-VP O
admitted VBN I-VP O
to TO B-PP O
the DT B-NP O
Internal NNP I-NP O
Medicine NNP I-NP O
under IN B-PP O
attending VBG B-VP O
Harold NNP B-NP B-DOCTOR
Crosby NNP I-NP I-DOCTOR
, , O O
M.D. NNP B-NP O
for IN B-PP O
renal JJ B-NP O
transplant NN I-NP O
biopsy NN I-NP O
. . O O
1 CD B-NP O
. . O O
Renal NNP O O
- : O O
slightly RB B-VP O
impaired VBN I-VP O
graft NN B-NP O
function NN I-NP O
, , O O
probaly RB B-ADVP O
due JJ B-PP O
to TO I-PP O
a DT B-NP O
combination NN I-NP O
of IN B-PP O
BPH NNP B-NP O
vs. CC O O
increased VBD B-VP O
sensitivity NN B-NP O
to TO B-PP O
FK NNP B-NP O
vs. CC O O
acute JJ B-NP O
rejection NN I-NP O
. . O O
Plan NNP O O
for IN B-PP O
renal JJ B-NP O
transplant NN I-NP O
bx NN I-NP O
this DT B-NP O
afternoon NN I-NP O
if IN B-PP O
possible JJ B-NP O
, , O O
if IN B-CONJP O
not RB I-CONJP O
possible JJ B-NP O
will MD B-VP O
do VB I-VP O
first JJ B-NP O
thing NN I-NP O
in IN B-PP O
the DT B-NP O
am VBP I-NP O
. . O O
2. DT B-NP O
Immunosuppression NNP I-NP O
- : O O
cont NN B-NP O
. . B-NP O
current JJ I-NP O
regimen NNS I-NP O
for IN B-PP O
now RB B-NP O
, , O O
pending VBG B-NP O
renal NN I-NP O
bx NN I-NP O
3. DT B-NP O
CVS- NNP I-NP O
well RB I-NP O
controlled JJ I-NP O
, , O O
however RB B-ADVP O
would MD B-VP O
d/c VB I-VP O
Diltiazem NNP B-NP O
and CC I-NP O
Hydralazine NNP I-NP O
given VBN B-VP O
renal JJ B-NP O
insufficiency NN I-NP O
. . O O
Would MD B-VP O
start VB I-VP O
Labetolol NNP B-NP O
200mg CD I-NP O
tid NN I-NP O
. . O O
4 CD B-LST O
. . O O
ID- -RRB- B-VP O
no DT B-NP O
concerns NNS I-NP O
, , O O
U/A NNP B-NP O
negative JJ I-NP O
5 CD B-NP O
. . O O
Heme NNP O O
- : O O
Hct NN B-NP O
stable NN I-NP O
, , O O
INR NNP B-NP O
1.1 CD I-NP O
, , O O
will MD B-VP O
send VB I-VP O
off RP B-NP O
type NN I-NP O
and CC O O
hold VB B-VP O
for IN B-PP O
biopsy NN B-NP O
. . O O
6 CD B-NP O
. . O O
Labs NNP B-NP O
- : O O
CBC NNP B-NP O
w/diff NN I-NP O
, , O O
BMP NNP B-NP O
, , O O
LDH NNP B-NP O
, , O O
PO4 NNP B-NP O
, , O O
albumin NN B-NP O
, , O O
tacrolimus NN B-NP O
level NN I-NP O
qam NN I-NP O
. . O O
Yuna NNP B-NP B-DOCTOR
K. NNP I-NP I-DOCTOR
Tripp NNP I-NP I-DOCTOR
,PA-C . O O
bb# NN B-NP O
62803 CD I-NP B-PHONE
Patient NNP B-NP O
seen VBN B-VP O
and CC I-VP O
examined VBN I-VP O
with IN B-PP O
renal JJ B-NP O
PA NNP I-NP O
I PRP B-NP O
agree VBP B-VP O
with IN B-PP O
the DT B-NP O
review NN I-NP O
of IN B-PP O
patient NN B-NP O
problems NNS I-NP O
, , O O
history NN B-NP O
, , O O
medication NN B-NP O
, , O O
physical JJ B-NP O
examination NN I-NP O
, , O O
assessment NN B-NP O
and CC I-NP O
plan NN I-NP O
as IN B-SBAR O
detailed VBN B-VP O
in IN B-PP O
the DT B-NP O
PA NNP I-NP O
note NN I-NP O
above IN B-PP O
. . B-NP O
Followup NNP I-NP O
clinic NN I-NP O
visit NN I-NP O
arranged VBD B-VP O
with IN B-PP O
patient NN B-NP O
. . O O
Case NNP B-NP O
was VBD B-VP O
discussed VBN I-VP O
with IN B-PP O
patient NN B-NP O
, , O O
renal JJ B-NP O
transplant NN I-NP O
nurse NN I-NP O
, , O O
and CC O O
pharmacist NN B-NP O
. . O O
Harold NNP B-NP B-DOCTOR
K. NNP I-NP I-DOCTOR
Crosby NNP I-NP I-DOCTOR
, , O O
M.D. NNP B-NP O
